Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone. [PDF]
Cipriano A +5 more
europepmc +1 more source
High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study. [PDF]
Mordal J +9 more
europepmc +1 more source
Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.
Snooks H +18 more
europepmc +1 more source
The cognitive neuroscience of ketamine in major depression. [PDF]
Costi S +4 more
europepmc +1 more source
Selective activation of SIGMAR1 in anterior cingulate cortex glutamatergic neurons facilitates comorbid pain in depression in male mice. [PDF]
Wang X +10 more
europepmc +1 more source
Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo-Controlled, Parallel Group, First-In-Human Study in Healthy Male Participants. [PDF]
van Ruissen MCE +6 more
europepmc +1 more source
Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle. [PDF]
Gonzalez Utrilla M +8 more
europepmc +1 more source
Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt. [PDF]
van Steenbergen H +5 more
europepmc +1 more source

